Linda Laux - Concepedia

Author

Linda Laux

Lurie Children's Hospital ORCID

Also Known As

Angus Wilfong, L. Laux, Linda C Laux, Linda C. Laux, Linda L. Laux, Linda Laux, Simone Mandelstam

Publications

Citations

H-Index

Concepts

All Affiliations

Lurie Children's Hospital Northwestern University Miami Children's Hospital University of California, San Francisco University of Colorado Denver

About

Linda Laux is an author at Lurie Children's Hospital specializing in medicine, neurology, and pediatrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	2.7K
2	Public Health	2	2	56
3	Social Sciences	2	2	179
4	Immunology	2	2	60
5	Child Development	1	1	21

Linda Laux

Publications

6.4K

Citations

H-Index

Page 1

	Year	Citations
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome Orrin Devinsky, J. Helen Cross, Linda Laux, New England Journal of Medicine	2017	1.6K
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial Orrin Devinsky, Eric D. Marsh, Daniel J. Friedman, The Lancet Neurology Cannabis UsePsychotropic MedicationNeuropharmacologyTreatment-resistant EpilepsyPharmacotherapy	2015	890
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial Elizabeth A. Thiele, Eric D. Marsh, Jacqueline A. French, The Lancet Placebo-controlled Phase 3NeuropharmacologyPharmacotherapyNeurologyMedicine	2018	868
Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial Lieven Lagae, Joseph Sullivan, Kelly G. Knupp, The Lancet Dravet SyndromeFenfluramine HydrochlorideMedicinePsychotropic MedicationNeuropharmacology	2019	348
Optimizing the Diagnosis and Management of Dravet Syndrome: Recommendations From a North American Consensus Panel Elaine Wirrell, Linda Laux, Elizabeth Donner, Pediatric Neurology MedicineInherited Metabolic DiseasePediatricsDravet Syndrome	2017	274
Long‐term cannabidiol treatment in patients with Dravet syndrome: An open‐label extension trial Orrin Devinsky, Rima Nabbout, Ian Miller, Epilepsia	2018	265
Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens Rima Nabbout, Arun Mistry, Sameer M. Zuberi, JAMA Neurology	2019	230
Cellular injury and neuroinflammation in children with chronic intractable epilepsy Jieun Choi, Douglas R. Nordli, Tord D. Alden, Journal of Neuroinflammation	2009	217
Long‐term safety and treatment effects of cannabidiol in children and adults with treatment‐resistant epilepsies: Expanded access program results Jerzy P. Szaflarski, E. Martina Bebin, Anne M. Comi, Epilepsia	2018	202
Open-label use of highly purified CBD (Epidiolex®) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes Orrin Devinsky, Chloe Verducci, Elizabeth A. Thiele, Epilepsy & Behavior	2018	183

Page 1